ology and the clinical implications of antigenic variation in a number of microorganisms, including Neisseria gonorrhoeae. Among a number of gonococcal surface antigens under intense scrutiny because of their postulated roles in pathogenesis are two that undergo both phase and antigenic variations: pili (or fimbriae) and an outer membrane protein designated P.II. Pili are surface fibrils made up of multiple subunits of r',19 kDa that function to increase adherence to a number of cell types [1]. P.II is a family of heat-modifiable proteins of 24-30 kDa, the presence of which is associated with increased intercellular adhesion between gonococci, and also with increased attachment to certain cells [2]. Phase variation or phase switching generally refers to reversible switches between alternative states, such as pilus-expressing (P+) or pilus nonexpressing (P-) and P.II expressing (PM+) or P.II nonexpressing (P.II-). The switch between these phases in vitro is a relatively high-frequency event. The P+ to 13phase variation occurs at an estimated frequency of ,N,10-2-10-3/cell per generation; the reverse switch from 13to P+ occurs at variable frequency from >10-2 to essentially undetectable. The phase variation between P.II+ and P.IIoccurs at f\40-2-10-3/cell per generation, apparently with equal rates in both directions [3]. These rates are too high to be explained by classical mutation events. Antigenic variation refers to alterations in structure that are accompanied by detectable alterations
No takes yet. Share an insight, caveat, or question.
Sparling et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: